| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 96,5 k € | -15.8% | 114,6 k € | +8.3% | 105,9 k € | +60.6% | 65,9 k € | -18.9% | 81,3 k € | +108.7% | 38,9 k € | -35.2% | 60,1 k € | -2.4% | 61,6 k € | +4.9% | 58,8 k € | -27.9% | 81,5 k € | +28.3% | 63,5 k € | -1.7% | 64,6 k € | +10.7% | 58,4 k € | -13.2% | 67,3 k € | +7.1% | 62,8 k € | -18.4% | 77,0 k € | +23.6% | 62,3 k € | -16.2% | 74,3 k € | +31.6% | 56,5 k € | |
| EBITDA | 95,2 k € | -15.9% | 113,2 k € | +8.4% | 104,4 k € | +62.1% | 64,4 k € | -19.3% | 79,9 k € | +114.3% | 37,3 k € | -36.6% | 58,8 k € | -2.0% | 60,0 k € | +5.2% | 57,0 k € | -28.7% | 80,0 k € | +29.1% | 61,9 k € | -2.0% | 63,2 k € | +12.0% | 56,5 k € | -14.5% | 66,0 k € | +7.1% | 61,7 k € | -18.7% | 75,9 k € | +23.2% | 61,6 k € | -16.3% | 73,6 k € | +32.1% | 55,7 k € | |
| Operating profit | 65,8 k € | -21.8% | 84,2 k € | -6.2% | 89,7 k € | +99.5% | 45,0 k € | -27.5% | 62,0 k € | +216.1% | 19,6 k € | -50.7% | 39,8 k € | -3.2% | 41,1 k € | -5.1% | 43,3 k € | -35.2% | 66,8 k € | +37.9% | 48,4 k € | -2.8% | 49,8 k € | +15.9% | 43,0 k € | -29.8% | 61,2 k € | +4.1% | 58,8 k € | -19.4% | 73,0 k € | +40.2% | 52,1 k € | -19.8% | 64,9 k € | +41.2% | 46,0 k € | |
| Profit/loss | 43,2 k € | -44.2% | 77,4 k € | +30.2% | 59,4 k € | +104.8% | 29,0 k € | -30.0% | 41,5 k € | +197.2% | 14,0 k € | -54.2% | 30,4 k € | +9.5% | 27,8 k € | +5.3% | 26,4 k € | -35.6% | 41,0 k € | +38.8% | 29,6 k € | -2.5% | 30,3 k € | +10.8% | 27,4 k € | -30.3% | 39,3 k € | +3.9% | 37,8 k € | -21.6% | 48,2 k € | +52.7% | 31,6 k € | -23.9% | 41,5 k € | +46.0% | 28,4 k € | |
| Equity | 187,4 k € | +1.1% | 185,2 k € | -0.0% | 185,2 k € | +47.2% | 125,8 k € | +30.0% | 96,8 k € | +14.0% | 84,9 k € | -0.1% | 85,0 k € | +0.1% | 84,9 k € | +0.0% | 84,9 k € | -0.1% | 85,0 k € | +93.4% | 44,0 k € | +205.7% | 14,4 k € | +0.2% | 14,4 k € | -0.2% | 14,4 k € | -0.3% | 14,4 k € | -1.6% | 14,7 k € | +1.3% | 14,5 k € | +76.1% | 8,2 k € | -0.2% | 8,2 k € | |
| Total assets | 232,1 k € | -26.4% | 315,5 k € | +36.3% | 231,4 k € | +31.5% | 176,0 k € | +22.0% | 144,3 k € | +0.9% | 143,0 k € | -12.6% | 163,6 k € | -6.1% | 174,3 k € | +13.5% | 153,7 k € | +13.9% | 134,9 k € | +55.3% | 86,9 k € | +20.0% | 72,4 k € | -38.3% | 117,4 k € | +80.4% | 65,1 k € | -30.2% | 93,3 k € | +34.0% | 69,7 k € | -28.2% | 97,1 k € | +35.3% | 71,7 k € | +18.7% | 60,4 k € | |
| Cash | 151,1 k € | -22.1% | 194,0 k € | +95.7% | 99,1 k € | -15.6% | 117,4 k € | +160.2% | 45,1 k € | +155.7% | 17,7 k € | -37.1% | 28,1 k € | +88.2% | 14,9 k € | -74.4% | 58,2 k € | +295.4% | 14,7 k € | +33.1% | 11,1 k € | -13.2% | 12,8 k € | +302.5% | 3,2 k € | -16.0% | 3,8 k € | +111.0% | 1,8 k € | -60.4% | 4,5 k € | -32.4% | 6,7 k € | +97.7% | 3,4 k € | +45.6% | 2,3 k € | |
| Debts | 41,0 k € | -68.4% | 129,5 k € | +181.1% | 46,1 k € | -6.2% | 49,1 k € | +5.5% | 46,6 k € | -18.9% | 57,4 k € | -26.4% | 78,0 k € | -12.2% | 88,8 k € | +29.2% | 68,7 k € | +40.0% | 49,1 k € | +23.2% | 39,8 k € | -27.5% | 54,9 k € | -46.7% | 103,1 k € | +103.2% | 50,7 k € | -35.2% | 78,2 k € | +42.2% | 55,0 k € | -33.4% | 82,6 k € | +31.4% | 62,9 k € | +20.4% | 52,2 k € | |
Private limited company · Grobbendonk · incorporated on 08/03/1999
Private limited company profitable and well capitalised. Cash position declining (-22.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. P. Bulteel is a Private limited company incorporated in 1999. Its main activity is: Other human health activities. Its registered office is in Grobbendonk.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.